FeesSafety
Pluang+

SpaceX shares rise 9% post-Q3 on strong AI unit growth and manageable 2027 targets

Company Fundamentals
26 Oct 2026, 23:09 WIB
Seeking Alpha
View Source
Bullish
SpaceX shares rise 9% post-Q3 on strong AI unit growth and manageable 2027 targets

SpaceX reported Q3 results that exceeded low expectations, driven by a significant increase in its Super Intelligence unit, now contributing 52% of total sales up from 32% last quarter. The company is focusing on leasing out compute capacity, which is becoming a key revenue stream. Elon Musk's ambitious 2027 targets remain a point of scrutiny, but the current market conditions favor SpaceX's growth prospects. The stock surged about 9% after the earnings announcement, reflecting investor optimism despite some outlook uncertainties.

SpaceX's recent Q3 results come with this Technology-sector market context from Pluang as of Oct 27, 2026 02:51 WIB: Among 150 priced US tech stocks, 81 rose and 65 fell today. Notable movers include Texas Instruments Incorporated (TXN) at USD 297.96 with a 4.66% increase, Fastly Inc (FSLY) at USD 25.50 rising 4.47%, and Analog Devices, Inc. (ADI) at USD 408.25 up 4.39%. The most notable figure is TXN's 65% Sell order activity on Pluang.

More News

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement, a self-custodial finance and payments platform, will release its third quarter 2026 financial results after market close on November 9, 2026. The company will host a webcast at 5:00 PM ET the same day to discuss the results. Founded ...

Company Fundamentals
Neutral
23 minutes ago
Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360, a leading independent specialty pharmacy, has been selected by AstraZeneca as a national pharmacy partner for Zegfrovy (sunvozertinib), a treatment for advanced non-small cell lung cancer with EGFR exon 20 insertion mutations. Zegfrovy has s...

Market News
Bullish
23 minutes ago
S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions has been accepted into the SAP PartnerEdge program, marking a key milestone in its growth. This partnership enhances S4A's ability to help organizations maximize their SAP investments, especially in areas like asset management and su...

Market News
Bullish
35 minutes ago
SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

Public companies are facing new challenges for the 2027 proxy season due to changes in SEC policies, evolving shareholder activism strategies, and shifts in institutional investor voting. A virtual roundtable on October 28 will gather experts to disc...

Market News
Neutral
2 hours ago
Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo Inc., a leading provider of in-flight broadband connectivity, announced it will report its third quarter 2026 financial results on November 6, 2026, before the market opens. The company will hold a conference call with financial analysts the sam...

Company Fundamentals
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App